Although our efforts have been largely responsible for delaying the prohormone legislation for two years now, I think the whole industry has been resigned to the fact that this legislation would ultimately pass. Today, Senator Biden was able to get this legislation passed in the Senate Judiciary Committee and it is now headed to the floor for a vote. If approved, the legislation would be sent to the House where I am told that the language of the Senate bill will likely be accepted. It appears that this may all transpire in the very near future, possibly as soon as within the next seven days. I will advise you immediately should this happen, but remember, the 90-day effective date is currently written into the bill.
We will continue to work day in and day out to represent the industry on issues that threaten our freedom of access to dietary supplements and the viability of the sports supplement industry. As we have previously discussed, creatine has been mentioned in the notes of numerous pieces of legislation, where it is compared to anabolic steroids and questions are raised with regard to its safety. Bitter Orange is currently on the chopping block, and we have reason to believe that FDA is investigating other "ephedra alternatives" that are prevalent in popular weight loss products. In addition, Senator Biden's staff made it clear that although the prohormone legislation has been severed from the AER provision, Senator Durbin intends to reintroduce that legislation next year and Senator Biden will certainly be supportive. Adverse Event Reporting brings us one step closer to Pre-Market Approval. Also, be aware that Gov. Schwarzenegger today signed a bill making it a misdemeanor (under Section 110423.2 of the Health and Safety Code) for any manufacturer, wholesaler, retailer, or other person, to sell, transfer, or otherwise furnish any of the following to a person under 18 years of age:
(1) A dietary supplement containing an ephedrine group alkaloid.
(2) A dietary supplement containing any of the following:
(A) Androstanediol.
(B) Androstanedione.
(C) Androstenedione.
(D) Norandrostenediol.
(E) Norandrostenedione.
(F) Dehydroepiandrosterone.
We will continue to work day in and day out to represent the industry on issues that threaten our freedom of access to dietary supplements and the viability of the sports supplement industry. As we have previously discussed, creatine has been mentioned in the notes of numerous pieces of legislation, where it is compared to anabolic steroids and questions are raised with regard to its safety. Bitter Orange is currently on the chopping block, and we have reason to believe that FDA is investigating other "ephedra alternatives" that are prevalent in popular weight loss products. In addition, Senator Biden's staff made it clear that although the prohormone legislation has been severed from the AER provision, Senator Durbin intends to reintroduce that legislation next year and Senator Biden will certainly be supportive. Adverse Event Reporting brings us one step closer to Pre-Market Approval. Also, be aware that Gov. Schwarzenegger today signed a bill making it a misdemeanor (under Section 110423.2 of the Health and Safety Code) for any manufacturer, wholesaler, retailer, or other person, to sell, transfer, or otherwise furnish any of the following to a person under 18 years of age:
(1) A dietary supplement containing an ephedrine group alkaloid.
(2) A dietary supplement containing any of the following:
(A) Androstanediol.
(B) Androstanedione.
(C) Androstenedione.
(D) Norandrostenediol.
(E) Norandrostenedione.
(F) Dehydroepiandrosterone.
Last edited: